Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group. অনুযায়ী Noseworthy, J, Vandervoort, M, Ebers, G

Plasma exchange for MS. অনুযায়ী Noseworthy, J, Vandervoort, M, Ebers, G

ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS অনুযায়ী Noseworthy, J, Vandervoort, M, Ebers, G

PLASMA-EXCHANGE FOR MS অনুযায়ী Noseworthy, J, Vandervoort, M, Ebers, G

Erratum: Plasma exchange for MS (Neurology (1990) 40 (864-866)) অনুযায়ী Noseworthy, J, Vandervoort, M, Ebers, G

EDSS RELIABILITY - REPLY অনুযায়ী Noseworthy, J, Vandervoort, M, Wong, C, Ebers, G

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. অনুযায়ী Noseworthy, J, Vandervoort, M, Wong, C, Ebers, G

MS REFERENDUM - REPLY অনুযায়ী Noseworthy, J, Vandervoort, M, Hopkins, M, Ebers, G

INTERRATER VARIABILITY WITH THE EXPANDED DISABILITY STATUS SCALE (EDSS) AND FUNCTIONAL-SYSTEMS (FS) IN A MULTIPLE-SCLEROSIS CLINICAL-TRIAL অনুযায়ী Noseworthy, J, Vandervoort, M, Wong, C, Ebers, G

A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop. অনুযায়ী Noseworthy, J, Vandervoort, M, Hopkins, M, Ebers, G

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article] অনুযায়ী Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial অনুযায়ী Nosworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. অনুযায়ী Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R

FAILURE TO FIND PATIENTS WITH NERVOUS-SYSTEM MANIFESTATIONS OF PRIMARY SJOGRENS SYNDROME IN A MULTIPLE-SCLEROSIS CLINIC POPULATION অনুযায়ী Noseworthy, J, Bass, B, Vandervoort, M, Ebers, G, Rice, G, Weinshenker, B, Bell, D

Seizures in multiple sclerosis: A multi-centre study অনুযায়ী Mandalfino, P, Koopman, W, Vandervoort, M, O'Connor, P, Hader, W, Brunet, D, Murray, T, Ebers, G

ACTIVE RELAPSING AND PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS HAVE SIMILAR MAGNETIC-RESONANCE-IMAGING BEHAVIOR - IMPLICATIONS FOR CLINICAL-TRIAL DESIGN অনুযায়ী Noseworthy, J, Karlik, S, Wiebe, S, Hopkins, M, Vandervoort, M, Hewitt, L, Rice, G, Ebers, G, Lee, D

SJOGRENS-SYNDROME MIMICKING MULTIPLE-SCLEROSIS - REPLY অনুযায়ী Noseworthy, J, Bass, B, Vandervoort, M, Ebers, G, Rice, G, Weinshenker, B, Mclay, C, Bell, D

The prevalence of primary Sjogren's syndrome in a multiple sclerosis population. অনুযায়ী Noseworthy, J, Bass, B, Vandervoort, M, Ebers, G, Rice, G, Weinshenker, BG, McLay, C, Bell, D

Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. অনুযায়ী Wiebe, S, Lee, D, Karlik, S, Hopkins, M, Vandervoort, M, Wong, C, Hewitt, L, Rice, G, Ebers, G, Noseworthy, J

An open-trial evaluation of mitoxantrone in the treatment of progressive MS. অনুযায়ী Noseworthy, J, Hopkins, M, Vandervoort, M, Karlik, S, Lee, D, Penman, M, Rice, G, Grinwich, K, Cauvier, H, Harris, B